Mohammad Ali Aziz-Sultan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Embolization, Therapeutic | 39 | 2024 | 1392 | 6.150 |
Why?
|
Polyvinyls | 16 | 2021 | 157 | 5.520 |
Why?
|
Intracranial Aneurysm | 34 | 2024 | 1197 | 4.670 |
Why?
|
Dimethyl Sulfoxide | 11 | 2021 | 249 | 3.890 |
Why?
|
Endovascular Procedures | 25 | 2024 | 1979 | 2.830 |
Why?
|
Subarachnoid Hemorrhage | 18 | 2021 | 1018 | 2.460 |
Why?
|
Cerebral Angiography | 22 | 2020 | 1285 | 2.390 |
Why?
|
Intracranial Arteriovenous Malformations | 5 | 2022 | 356 | 1.380 |
Why?
|
Tantalum | 3 | 2013 | 56 | 1.220 |
Why?
|
Vertebral Artery Dissection | 2 | 2016 | 48 | 1.110 |
Why?
|
Aneurysm, Ruptured | 9 | 2022 | 452 | 1.100 |
Why?
|
Neurosurgical Procedures | 9 | 2020 | 2002 | 1.080 |
Why?
|
Carotid Artery Diseases | 6 | 2022 | 882 | 0.980 |
Why?
|
Retinal Neoplasms | 3 | 2011 | 144 | 0.980 |
Why?
|
Stents | 8 | 2023 | 3280 | 0.960 |
Why?
|
Retinoblastoma | 3 | 2011 | 318 | 0.930 |
Why?
|
Cerebral Revascularization | 6 | 2022 | 238 | 0.870 |
Why?
|
Enbucrilate | 2 | 2014 | 31 | 0.860 |
Why?
|
Surgical Instruments | 3 | 2018 | 395 | 0.810 |
Why?
|
Brain Ischemia | 10 | 2022 | 3265 | 0.790 |
Why?
|
Vertebrobasilar Insufficiency | 3 | 2018 | 114 | 0.790 |
Why?
|
Carotid-Cavernous Sinus Fistula | 3 | 2010 | 40 | 0.780 |
Why?
|
Stroke | 14 | 2022 | 9981 | 0.760 |
Why?
|
Angiofibroma | 2 | 2011 | 68 | 0.760 |
Why?
|
Punctures | 2 | 2013 | 374 | 0.740 |
Why?
|
Ophthalmic Artery | 2 | 2011 | 60 | 0.740 |
Why?
|
Injections, Intra-Arterial | 3 | 2014 | 193 | 0.700 |
Why?
|
Visual Pathways | 2 | 2013 | 565 | 0.680 |
Why?
|
Vascular Neoplasms | 2 | 2011 | 175 | 0.680 |
Why?
|
Vasospasm, Intracranial | 5 | 2021 | 208 | 0.670 |
Why?
|
Melphalan | 2 | 2011 | 431 | 0.660 |
Why?
|
Ischemia | 3 | 2017 | 1907 | 0.660 |
Why?
|
Nasopharyngeal Neoplasms | 2 | 2011 | 286 | 0.650 |
Why?
|
Brain Infarction | 3 | 2019 | 299 | 0.640 |
Why?
|
Moyamoya Disease | 4 | 2022 | 238 | 0.620 |
Why?
|
Vertebral Artery | 5 | 2017 | 192 | 0.610 |
Why?
|
Neuronavigation | 1 | 2019 | 167 | 0.610 |
Why?
|
Carotid Artery, External | 1 | 2017 | 38 | 0.600 |
Why?
|
Embolectomy | 1 | 2017 | 120 | 0.580 |
Why?
|
Myxoma | 1 | 2017 | 130 | 0.580 |
Why?
|
Brain Stem Infarctions | 1 | 2016 | 32 | 0.560 |
Why?
|
Renal Artery Obstruction | 1 | 2017 | 248 | 0.550 |
Why?
|
Angiography, Digital Subtraction | 6 | 2021 | 341 | 0.550 |
Why?
|
Treatment Outcome | 47 | 2024 | 63114 | 0.540 |
Why?
|
Craniotomy | 3 | 2017 | 729 | 0.530 |
Why?
|
Cranial Nerve Diseases | 2 | 2013 | 112 | 0.530 |
Why?
|
Renal Artery | 1 | 2017 | 398 | 0.530 |
Why?
|
Cerebral Infarction | 4 | 2016 | 1011 | 0.500 |
Why?
|
Embolism | 1 | 2017 | 408 | 0.480 |
Why?
|
Heart Neoplasms | 1 | 2017 | 374 | 0.480 |
Why?
|
Glomus Jugulare Tumor | 1 | 2013 | 37 | 0.470 |
Why?
|
Cerebellopontine Angle | 1 | 2013 | 55 | 0.470 |
Why?
|
Optic Chiasm | 1 | 2013 | 87 | 0.460 |
Why?
|
Epistaxis | 1 | 2014 | 111 | 0.460 |
Why?
|
Preoperative Care | 5 | 2019 | 2250 | 0.460 |
Why?
|
Oropharynx | 1 | 2014 | 127 | 0.460 |
Why?
|
Cerebral Arterial Diseases | 1 | 2013 | 82 | 0.460 |
Why?
|
Infratentorial Neoplasms | 1 | 2013 | 94 | 0.440 |
Why?
|
Cerebral Veins | 1 | 2014 | 156 | 0.430 |
Why?
|
Carotid Artery, Internal | 6 | 2014 | 445 | 0.390 |
Why?
|
Subarachnoid Space | 1 | 2011 | 79 | 0.390 |
Why?
|
Decompressive Craniectomy | 3 | 2017 | 72 | 0.380 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2017 | 934 | 0.380 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2011 | 80 | 0.380 |
Why?
|
Paracoccidioidomycosis | 1 | 2009 | 9 | 0.370 |
Why?
|
Orbit | 2 | 2010 | 426 | 0.360 |
Why?
|
Retinal Artery | 1 | 2010 | 111 | 0.350 |
Why?
|
Middle Aged | 52 | 2022 | 213383 | 0.350 |
Why?
|
Fibrinolytic Agents | 2 | 2022 | 2158 | 0.340 |
Why?
|
Magnetic Resonance Angiography | 7 | 2019 | 1442 | 0.340 |
Why?
|
Operating Rooms | 1 | 2016 | 817 | 0.340 |
Why?
|
Aneurysm, Infected | 1 | 2009 | 85 | 0.340 |
Why?
|
Carotid Body Tumor | 1 | 2009 | 32 | 0.330 |
Why?
|
Blindness | 1 | 2013 | 617 | 0.330 |
Why?
|
Tissue Plasminogen Activator | 2 | 2017 | 1261 | 0.330 |
Why?
|
Humans | 100 | 2024 | 744343 | 0.320 |
Why?
|
Carcinoma, Renal Cell | 2 | 2013 | 3143 | 0.320 |
Why?
|
Brain Stem | 1 | 2013 | 846 | 0.320 |
Why?
|
Brain Neoplasms | 5 | 2019 | 8863 | 0.320 |
Why?
|
Laser Coagulation | 1 | 2010 | 326 | 0.320 |
Why?
|
Catheterization | 2 | 2010 | 1470 | 0.310 |
Why?
|
Catheters | 1 | 2011 | 425 | 0.310 |
Why?
|
Infusions, Intra-Arterial | 3 | 2014 | 234 | 0.300 |
Why?
|
Monitoring, Intraoperative | 1 | 2014 | 957 | 0.290 |
Why?
|
Kidney Neoplasms | 2 | 2013 | 4262 | 0.290 |
Why?
|
Retrospective Studies | 33 | 2024 | 77449 | 0.290 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2016 | 1390 | 0.290 |
Why?
|
Scalp | 1 | 2009 | 380 | 0.290 |
Why?
|
Blood Coagulation Disorders | 1 | 2009 | 337 | 0.280 |
Why?
|
Angioplasty, Balloon | 2 | 2009 | 653 | 0.280 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2010 | 627 | 0.270 |
Why?
|
Male | 55 | 2022 | 350118 | 0.270 |
Why?
|
Female | 58 | 2022 | 380194 | 0.260 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 642 | 0.260 |
Why?
|
Drainage | 1 | 2011 | 1142 | 0.260 |
Why?
|
Thrombectomy | 3 | 2022 | 680 | 0.250 |
Why?
|
Fluoroscopy | 3 | 2016 | 924 | 0.250 |
Why?
|
Saphenous Vein | 2 | 2018 | 532 | 0.250 |
Why?
|
Glioma | 2 | 2019 | 3401 | 0.250 |
Why?
|
Hemangioma | 1 | 2009 | 738 | 0.240 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2014 | 65 | 0.240 |
Why?
|
Hemodynamics | 1 | 2014 | 4199 | 0.230 |
Why?
|
Blood Vessel Prosthesis | 2 | 2020 | 933 | 0.230 |
Why?
|
Reperfusion | 2 | 2014 | 284 | 0.230 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1475 | 0.220 |
Why?
|
Aged | 36 | 2021 | 163280 | 0.220 |
Why?
|
Cerebral Cortex | 1 | 2019 | 5708 | 0.210 |
Why?
|
Hemianopsia | 2 | 2013 | 122 | 0.210 |
Why?
|
Adult | 34 | 2022 | 214055 | 0.200 |
Why?
|
Thrombocytopenia | 1 | 2009 | 1179 | 0.200 |
Why?
|
Magnetic Resonance Imaging | 11 | 2019 | 35421 | 0.200 |
Why?
|
Tomography, X-Ray Computed | 8 | 2019 | 20129 | 0.200 |
Why?
|
Angiography | 5 | 2014 | 1639 | 0.190 |
Why?
|
Aneurysm, False | 2 | 2017 | 276 | 0.180 |
Why?
|
Radiography | 5 | 2014 | 7023 | 0.170 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2021 | 292 | 0.170 |
Why?
|
Cranial Sinuses | 1 | 2019 | 66 | 0.170 |
Why?
|
Meningioma | 2 | 2021 | 1209 | 0.170 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2020 | 125 | 0.160 |
Why?
|
Meningeal Neoplasms | 2 | 2021 | 1241 | 0.160 |
Why?
|
Head and Neck Neoplasms | 2 | 2012 | 2734 | 0.160 |
Why?
|
Postoperative Complications | 8 | 2019 | 15295 | 0.160 |
Why?
|
Collateral Circulation | 1 | 2019 | 287 | 0.160 |
Why?
|
Young Adult | 12 | 2019 | 56430 | 0.160 |
Why?
|
Imaging, Three-Dimensional | 3 | 2019 | 4042 | 0.160 |
Why?
|
Regional Blood Flow | 2 | 2013 | 1525 | 0.150 |
Why?
|
Aged, 80 and over | 14 | 2019 | 57776 | 0.150 |
Why?
|
Infarction | 2 | 2022 | 244 | 0.150 |
Why?
|
Perioperative Period | 1 | 2019 | 256 | 0.150 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 284 | 0.150 |
Why?
|
Propensity Score | 2 | 2024 | 1781 | 0.150 |
Why?
|
Drug Combinations | 2 | 2013 | 1959 | 0.150 |
Why?
|
Paresthesia | 1 | 2018 | 161 | 0.150 |
Why?
|
Arteriovenous Fistula | 1 | 2020 | 315 | 0.150 |
Why?
|
Databases, Bibliographic | 1 | 2017 | 128 | 0.150 |
Why?
|
Blood Loss, Surgical | 2 | 2011 | 662 | 0.140 |
Why?
|
Cross Infection | 2 | 2016 | 1416 | 0.140 |
Why?
|
Vascular Grafting | 1 | 2018 | 142 | 0.140 |
Why?
|
Prospective Studies | 9 | 2023 | 53288 | 0.130 |
Why?
|
Aneurysm | 1 | 2019 | 339 | 0.130 |
Why?
|
Reaction Time | 1 | 2022 | 2097 | 0.130 |
Why?
|
Occipital Lobe | 1 | 2017 | 379 | 0.130 |
Why?
|
Follow-Up Studies | 11 | 2021 | 39050 | 0.130 |
Why?
|
Patient Readmission | 3 | 2019 | 3114 | 0.130 |
Why?
|
Tracheostomy | 1 | 2018 | 401 | 0.130 |
Why?
|
Graft Occlusion, Vascular | 1 | 2018 | 549 | 0.120 |
Why?
|
Serotonin Agents | 1 | 2014 | 29 | 0.120 |
Why?
|
Thrombolytic Therapy | 2 | 2022 | 2161 | 0.120 |
Why?
|
Intracranial Hemorrhages | 1 | 2020 | 855 | 0.120 |
Why?
|
Blister | 1 | 2014 | 86 | 0.120 |
Why?
|
Endarterectomy, Carotid | 1 | 2019 | 546 | 0.120 |
Why?
|
Combined Modality Therapy | 4 | 2014 | 8642 | 0.120 |
Why?
|
Basilar Artery | 1 | 2014 | 200 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11524 | 0.120 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2017 | 475 | 0.110 |
Why?
|
Time Factors | 9 | 2021 | 40075 | 0.110 |
Why?
|
Adolescent | 13 | 2019 | 85781 | 0.110 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 316 | 0.110 |
Why?
|
Paralysis | 1 | 2013 | 247 | 0.100 |
Why?
|
Inpatients | 3 | 2018 | 2518 | 0.100 |
Why?
|
Pandemics | 2 | 2022 | 8388 | 0.100 |
Why?
|
Microsurgery | 1 | 2017 | 796 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15540 | 0.100 |
Why?
|
Age Distribution | 2 | 2015 | 2902 | 0.100 |
Why?
|
Tinnitus | 1 | 2013 | 195 | 0.100 |
Why?
|
Eye Enucleation | 1 | 2011 | 128 | 0.100 |
Why?
|
Fever | 1 | 2018 | 1616 | 0.100 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2012 | 145 | 0.090 |
Why?
|
Registries | 4 | 2021 | 8089 | 0.090 |
Why?
|
Needles | 1 | 2013 | 449 | 0.090 |
Why?
|
Accidents, Traffic | 1 | 2016 | 819 | 0.090 |
Why?
|
Carotid Artery, Common | 1 | 2011 | 183 | 0.090 |
Why?
|
Patient Transfer | 1 | 2017 | 761 | 0.090 |
Why?
|
Neuralgia | 1 | 2017 | 570 | 0.090 |
Why?
|
Ophthalmoscopy | 1 | 2011 | 176 | 0.090 |
Why?
|
Nerve Block | 1 | 2017 | 644 | 0.090 |
Why?
|
Hospital Mortality | 4 | 2017 | 5317 | 0.090 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2010 | 85 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2016 | 1462 | 0.090 |
Why?
|
Sclerosis | 1 | 2010 | 213 | 0.090 |
Why?
|
Skin Neoplasms | 1 | 2009 | 5686 | 0.090 |
Why?
|
Spinal Puncture | 1 | 2011 | 281 | 0.090 |
Why?
|
Hypoglossal Nerve Diseases | 1 | 2009 | 8 | 0.090 |
Why?
|
Nasal Obstruction | 1 | 2011 | 151 | 0.090 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 788 | 0.090 |
Why?
|
Synovial Cyst | 1 | 2009 | 35 | 0.080 |
Why?
|
Clostridium Infections | 1 | 2016 | 548 | 0.080 |
Why?
|
Etoposide | 1 | 2010 | 641 | 0.080 |
Why?
|
Atlanto-Axial Joint | 1 | 2009 | 61 | 0.080 |
Why?
|
Child | 8 | 2017 | 77709 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2585 | 0.080 |
Why?
|
Arteries | 1 | 2013 | 1119 | 0.080 |
Why?
|
Cerebrovascular Circulation | 2 | 2021 | 2731 | 0.080 |
Why?
|
Nasopharynx | 1 | 2011 | 379 | 0.080 |
Why?
|
Vincristine | 1 | 2010 | 1039 | 0.080 |
Why?
|
North America | 2 | 2022 | 1249 | 0.080 |
Why?
|
Steroids | 1 | 2013 | 930 | 0.080 |
Why?
|
Cyclosporine | 1 | 2010 | 786 | 0.080 |
Why?
|
Anxiety | 1 | 2022 | 4297 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13695 | 0.080 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 2872 | 0.080 |
Why?
|
Nerve Compression Syndromes | 1 | 2009 | 160 | 0.070 |
Why?
|
Carboplatin | 1 | 2010 | 801 | 0.070 |
Why?
|
Calcinosis | 2 | 2014 | 1499 | 0.070 |
Why?
|
Zygapophyseal Joint | 1 | 2009 | 129 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3310 | 0.070 |
Why?
|
Intracranial Embolism | 1 | 2008 | 202 | 0.070 |
Why?
|
Intraoperative Complications | 2 | 2010 | 1198 | 0.070 |
Why?
|
Fluorescein Angiography | 1 | 2010 | 940 | 0.070 |
Why?
|
Spinal Cord | 1 | 2014 | 1809 | 0.070 |
Why?
|
Veins | 1 | 2010 | 770 | 0.070 |
Why?
|
Infant | 4 | 2012 | 35136 | 0.070 |
Why?
|
Incidence | 4 | 2021 | 20947 | 0.070 |
Why?
|
Blood Glucose | 1 | 2020 | 6256 | 0.060 |
Why?
|
Insulin | 1 | 2020 | 6580 | 0.060 |
Why?
|
Remission Induction | 1 | 2010 | 2386 | 0.060 |
Why?
|
Anesthesia, General | 1 | 2011 | 1171 | 0.060 |
Why?
|
Cohort Studies | 6 | 2024 | 40561 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15226 | 0.060 |
Why?
|
Length of Stay | 4 | 2019 | 6309 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5985 | 0.060 |
Why?
|
Swine | 1 | 2014 | 5917 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 1790 | 0.060 |
Why?
|
Syndrome | 1 | 2009 | 3251 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6895 | 0.060 |
Why?
|
Myocardial Infarction | 2 | 2021 | 11727 | 0.060 |
Why?
|
Blood Pressure | 2 | 2021 | 8554 | 0.060 |
Why?
|
Ischemic Attack, Transient | 1 | 2009 | 935 | 0.060 |
Why?
|
Data Collection | 1 | 2011 | 3341 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3461 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3582 | 0.050 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 2647 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2716 | 0.050 |
Why?
|
Milrinone | 1 | 2021 | 84 | 0.050 |
Why?
|
Endoscopy | 1 | 2011 | 1785 | 0.050 |
Why?
|
Visual Acuity | 1 | 2010 | 2530 | 0.050 |
Why?
|
Learning Curve | 1 | 2022 | 208 | 0.050 |
Why?
|
Retreatment | 1 | 2022 | 610 | 0.050 |
Why?
|
Child, Preschool | 3 | 2012 | 41006 | 0.040 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 2019 | 12 | 0.040 |
Why?
|
Lateral Sinus Thrombosis | 1 | 2019 | 8 | 0.040 |
Why?
|
Algorithms | 2 | 2017 | 13881 | 0.040 |
Why?
|
Comorbidity | 3 | 2019 | 10388 | 0.040 |
Why?
|
Spectrum Analysis | 1 | 2021 | 454 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 9959 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2021 | 326 | 0.040 |
Why?
|
Glioblastoma | 1 | 2014 | 3481 | 0.040 |
Why?
|
Skull Base | 1 | 2021 | 306 | 0.040 |
Why?
|
Phlebography | 1 | 2019 | 333 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 23338 | 0.040 |
Why?
|
Prognosis | 4 | 2021 | 29063 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4258 | 0.040 |
Why?
|
Recurrence | 2 | 2021 | 8340 | 0.040 |
Why?
|
Pediatrics | 1 | 2012 | 3475 | 0.040 |
Why?
|
Cerebellar Diseases | 1 | 2019 | 226 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2021 | 1423 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 354 | 0.040 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 214 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1677 | 0.030 |
Why?
|
Odds Ratio | 2 | 2021 | 9849 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7149 | 0.030 |
Why?
|
Age Factors | 3 | 2019 | 18370 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11031 | 0.030 |
Why?
|
United States | 6 | 2019 | 69872 | 0.030 |
Why?
|
Hospital Charges | 1 | 2017 | 362 | 0.030 |
Why?
|
Vascular Patency | 1 | 2018 | 886 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1337 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18029 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2018 | 930 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7729 | 0.030 |
Why?
|
Risk Factors | 5 | 2021 | 72290 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 789 | 0.030 |
Why?
|
Brain | 1 | 2021 | 26385 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14722 | 0.030 |
Why?
|
Logistic Models | 2 | 2020 | 13408 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 8949 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1170 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4644 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2020 | 861 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2019 | 854 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2022 | 1916 | 0.030 |
Why?
|
Glasgow Coma Scale | 1 | 2013 | 570 | 0.020 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 5751 | 0.020 |
Why?
|
Hydrocephalus | 1 | 2017 | 748 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2297 | 0.020 |
Why?
|
Forehead | 1 | 2010 | 69 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2859 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2010 | 125 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12959 | 0.020 |
Why?
|
Social Class | 1 | 2017 | 1999 | 0.020 |
Why?
|
Eyelids | 1 | 2010 | 265 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2014 | 975 | 0.020 |
Why?
|
Reoperation | 1 | 2017 | 4201 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5952 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1831 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2737 | 0.020 |
Why?
|
Hypertension | 2 | 2019 | 8480 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 13284 | 0.020 |
Why?
|
Insurance, Health | 1 | 2017 | 2494 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1671 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10252 | 0.020 |
Why?
|
Hospitals | 1 | 2017 | 3952 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12245 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12354 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 8987 | 0.010 |
Why?
|
Postoperative Care | 1 | 2009 | 1486 | 0.010 |
Why?
|
Quality Improvement | 1 | 2017 | 3749 | 0.010 |
Why?
|
Animals | 1 | 2014 | 168757 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12788 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6487 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 25625 | 0.010 |
Why?
|